APLLTD.BO
Alembic Pharmaceuticals Limited
BSEINREQUITY
Healthcare
DELAYED
Last price
820.50
▲ 6.15 (0.76%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
814.35
Prev close
814.35
Day high
825.60
Day low
814.30
Volume
2.07K
Market cap
$161.57B
P/E (TTM)
23.30
52W range
635.30 – 998.00
Day trading desk
Gap from prior close
0.00%
Prior close 814.35
VWAP
822.38
-0.23% from price
Relative volume
0.12×
Quiet session
Session range
1.38%
814.35 – 825.60
Position in range
55%
Mid range
ATR (14D)
20.93
2.55% of price
Prior day high
825.25
PDH
Prior day low
812.00
PDL
Bid / ask spread
—
Quote not published
Session volume
2.04K
Avg 17.65K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.29%
+0.1%
1M
+3.33%
-0.4%
3M
+8.11%
+5.0%
6M
+5.70%
-5.4%
YTD
-3.27%
-15.6%
1Y
-15.70%
-35.7%
3Y
+5.84%
-68.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on APLLTD.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
138.92M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 18, 26 | Nirayu Pvt. Ltd Promoter |
BUY | 3.28K | $25.84K | Direct |
| Jun 17, 26 | Nirayu Pvt. Ltd Promoter |
BUY | 24.83K | $196.06K | Direct |
| Jun 11, 26 | Nirayu Pvt. Ltd Promoter |
BUY | 75.00K | $584.29K | Direct |
| May 29, 26 | Nirayu Pvt. Ltd Promoter |
BUY | 20.00K | $156.63K | Direct |
| May 27, 26 | Nirayu Pvt. Ltd Promoter |
BUY | 138.00K | $1.10M | Direct |
| Sep 29, 25 | Nirayu Pvt. Ltd Promoter |
BUY | 10.00K | $101.89K | Direct |
| Sep 26, 25 | Nirayu Pvt. Ltd Promoter |
BUY | 5.00K | $50.86K | Direct |
| Sep 25, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 15.00K | $156.42K | Direct |
| Sep 15, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 5.20K | $56.80K | Direct |
| Sep 10, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 25.00K | $272.43K | Direct |
| Sep 9, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 20.00K | $214.93K | Direct |
| Sep 4, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 13.07K | $142.80K | Direct |
| Sep 3, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 20.00K | $217.16K | Direct |
| Sep 2, 25 | Amin (Chirayu Ramanbhai) HUF Promoter |
BUY | 13.29K | $142.18K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Amin (Chirayu Ramanbhai) HUF |
Promoter | 941.54K | Acquisition |
Nirayu Pvt. Ltd |
Promoter | 70.33M | Acquisition |
Fundamentals
Market cap$161.57B
Enterprise value$173.56B
Revenue (TTM)$77.84B
Gross profit$54.92B
EBITDA$11.35B
Net income$6.93B
EPS (TTM)$35.28
Free cash flow—
Total cash$1.96B
Total debt$14.30B
Book value / share$288.70
Shares outstanding196.56M
Float57.65M
Short % of float—
Dividend yield1.46%
Beta (5Y)0.30
Valuation & profitability ratios
Trailing P/E23.30
Forward P/E17.12
PEG ratio—
Price / sales—
Price / book2.85
EV / revenue2.23
EV / EBITDA15.30
Gross margin70.56%
Operating margin10.89%
Profit margin8.91%
Return on equity—
Return on assets—
Debt / equity25.22
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $72.13B | $65.40B | $61.12B | $55.00B | +10.3% |
| Operating revenue | $72.13B | $65.40B | $61.12B | $55.00B | +10.3% |
| Cost of revenue | $23.60B | $21.37B | $20.01B | $20.23B | +10.4% |
| Gross profit | $48.53B | $44.03B | $41.11B | $34.77B | +10.2% |
| Research & development | $378.30M | $96.00M | $209.80M | $290.70M | +294.1% |
| Selling, general & admin | $14.12B | $13.45B | $12.49B | $11.93B | +4.9% |
| Total operating expense | $40.49B | $36.68B | $34.48B | $30.33B | +10.4% |
| Operating income | $8.04B | $7.35B | $6.64B | $4.44B | +9.4% |
| Net interest income | -$927.70M | -$728.10M | -$541.00M | -$498.40M | -27.4% |
| Pre-tax income | $6.94B | $7.07B | $6.32B | $3.55B | -1.9% |
| Tax provision | $231.20M | $1.25B | $160.00M | $126.10M | -81.5% |
| Net income | $6.75B | $5.83B | $6.16B | $3.42B | +15.7% |
| Net income to common | $6.75B | $5.83B | $6.16B | $3.42B | +15.7% |
| Basic EPS | 34.33 | 29.68 | 31.33 | 17.40 | +15.7% |
| Diluted EPS | 34.33 | 29.68 | 31.33 | 17.40 | +15.7% |
| EBIT | $7.88B | $7.86B | $6.88B | $4.05B | +0.2% |
| EBITDA | $11.06B | $10.65B | $9.61B | $6.80B | +3.9% |
| Basic shares | 196.56M | 196.56M | 196.56M | 196.56M | 0.0% |
| Diluted shares | 196.56M | 196.56M | 196.56M | 196.56M | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.96B | $834.80M | $1.20B | $754.80M | — | +135.2% |
| Cash & short-term investments | $1.96B | $834.80M | $1.20B | $754.80M | — | +135.2% |
| Accounts receivable | $14.66B | $14.00B | $10.25B | $10.46B | — | +4.8% |
| Inventory | $25.11B | $22.88B | $16.44B | $14.75B | — | +9.7% |
| Total current assets | $45.43B | $40.88B | $30.79B | $29.10B | — | +11.1% |
| Property, plant & equipment | $34.93B | $33.92B | $30.71B | $30.00B | — | +3.0% |
| Goodwill & intangibles | $2.87B | $0 | $0 | $0 | — | — |
| Total assets | $87.63B | $77.73B | $64.46B | $61.83B | — | +12.7% |
| Total current liabilities | $25.94B | $24.12B | $14.55B | $16.37B | — | +7.5% |
| Current debt | $12.39B | $11.96B | $4.30B | $6.36B | — | +3.6% |
| Long-term debt | $1.22B | $0 | — | — | $0 | — |
| Total debt | $14.30B | $12.57B | $5.13B | $7.22B | — | +13.7% |
| Total liabilities | $30.94B | $25.83B | $16.27B | $18.12B | — | +19.7% |
| Retained earnings | $48.54B | $43.94B | $40.27B | $35.68B | — | +10.5% |
| Shareholder equity | $56.75B | $51.91B | $48.18B | $43.70B | — | +9.3% |
| Working capital | $19.49B | $16.75B | $16.24B | $12.73B | — | +16.3% |
| Net tangible assets | $53.88B | $51.91B | $48.18B | $43.70B | — | +3.8% |
| Shares issued | 196.56M | 196.56M | 196.56M | 196.56M | — | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $6.94B | $7.07B | $6.32B | $3.55B | -1.9% |
| Depreciation & amortisation | $3.19B | $2.79B | $2.73B | $2.75B | +14.3% |
| Change in working capital | -$2.57B | -$9.21B | -$956.50M | -$575.60M | +72.1% |
| Operating cash flow | $7.83B | $879.70M | $8.03B | $7.24B | +789.8% |
| Capital expenditure | -$4.95B | -$5.64B | -$3.27B | -$4.43B | +12.2% |
| Investing cash flow | -$5.06B | -$5.68B | -$3.21B | -$4.48B | +11.0% |
| Dividends paid | -$2.16B | -$2.16B | -$1.57B | -$1.97B | 0.0% |
| Financing cash flow | -$1.64B | $4.44B | -$4.38B | -$2.62B | -136.9% |
| Free cash flow | $2.88B | -$4.76B | $4.76B | $2.81B | +160.5% |
| End cash position | $1.96B | $834.80M | $1.20B | $754.80M | +135.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $21.50B | $18.48B | $18.76B | $17.11B | $17.70B | +16.3% |
| Operating revenue | $21.50B | $18.48B | $18.76B | $17.11B | $17.70B | +16.3% |
| Cost of revenue | $6.20B | $5.32B | $5.29B | $4.07B | $5.31B | +16.5% |
| Gross profit | $15.30B | $13.16B | $13.47B | $13.03B | $12.39B | +16.3% |
| Total operating expense | $12.96B | $11.76B | $11.34B | $10.96B | $10.36B | +10.1% |
| Operating income | $2.34B | $1.39B | $2.13B | $2.08B | $2.03B | +68.1% |
| Net interest income | -$276.10M | -$225.60M | -$233.10M | -$235.20M | -$245.20M | -22.4% |
| Pre-tax income | $2.22B | $1.19B | $1.61B | $1.90B | $1.92B | +87.0% |
| Tax provision | $495.00M | -$829.10M | $295.40M | $364.80M | $353.10M | +159.7% |
| Net income | $1.73B | $2.03B | $1.33B | $1.54B | $1.57B | -14.6% |
| Net income to common | $1.73B | $2.03B | $1.33B | $1.54B | $1.57B | -14.6% |
| Basic EPS | 8.80 | 10.31 | 6.76 | 7.85 | 7.98 | -14.6% |
| Diluted EPS | 8.80 | 10.31 | 6.76 | 7.85 | 7.98 | -14.6% |
| EBIT | $2.49B | $1.41B | $1.85B | $2.14B | $2.16B | +76.7% |
| EBITDA | $3.47B | $2.30B | $2.65B | $2.87B | $2.85B | +51.1% |
| Basic shares | 196.67M | 196.61M | 196.70M | 196.66M | 196.60M | +0.0% |
| Diluted shares | 196.67M | 196.61M | 196.70M | 196.66M | 196.60M | +0.0% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $1.96B | $834.80M | +135.2% |
| Cash & short-term investments | $1.96B | $834.80M | +135.2% |
| Accounts receivable | $14.66B | $14.00B | +4.8% |
| Inventory | $25.11B | $22.88B | +9.7% |
| Total current assets | $45.43B | $40.88B | +11.1% |
| Property, plant & equipment | $34.93B | $33.92B | +3.0% |
| Goodwill & intangibles | $2.87B | $0 | — |
| Total assets | $87.63B | $77.73B | +12.7% |
| Total current liabilities | $25.94B | $24.12B | +7.5% |
| Current debt | $12.39B | $11.96B | +3.6% |
| Long-term debt | $1.22B | $0 | — |
| Total debt | $14.30B | $12.57B | +13.7% |
| Total liabilities | $30.94B | $25.83B | +19.7% |
| Retained earnings | $48.54B | $43.94B | +10.5% |
| Shareholder equity | $56.75B | $51.91B | +9.3% |
| Working capital | $19.49B | $16.75B | +16.3% |
| Net tangible assets | $53.88B | $51.91B | +3.8% |
| Shares issued | 196.56M | 196.56M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 7.79 | 8.80 | +13.0% |
| Mar 2026 | 8.96 | 11.57 | +29.2% |
| Dec 2025 | 9.14 | 8.51 | -6.9% |
| Sep 2025 | 8.70 | 9.40 | +8.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 9.20 | 1 | $21.65B | +13.3% |
| Next quarter | 10.70 | 1 | $22.10B | +17.8% |
| Current year | 36.99 | 9 | $84.17B | +14.6% |
| Next year | 48.02 | 10 | $92.45B | +9.8% |
Analyst targets & ownership
Mean target$949.30
High target$1,132.00
Low target$800.00
Implied upside15.70%
Analyst count10
ConsensusNONE
Strong buy / Buy2 / 4
Hold3
Sell / Strong sell1 / 0
Held by insiders70.67%
Held by institutions17.07%
Institutions holding43
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
827.26
-0.82% from price
SMA 20
820.48
+0.00% from price
SMA 50
809.73
+1.33% from price
SMA 100
777.72
+5.50% from price
SMA 200
792.70
+3.51% from price
EMA 12
822.67
-0.26% from price
EMA 26
819.16
+0.16% from price
EMA 50
807.64
+1.59% from price
RSI (14)
50.9
Neutral
MACD (12,26,9)
3.50
Hist -2.03
ATR (14)
20.93
2.55% of price
Realised vol 30D
21.9%
Annualised
Bollinger upper
844.65
20, 2σ
Bollinger lower
796.32
20, 2σ
50 / 200 cross
Golden
809.73 vs 792.70
Trend bias
Above 200
+3.51%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.29
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
21.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-34.8%
Peak to trough
Max drawdown 5Y
-48.2%
Peak to trough
ATR 14
20.93
2.55% of price
Beta (reported)
0.30
5Y monthly, from filing
Dividends & splits
Forward rate$12.00 / yr
Forward yield1.46%
5-year avg yield1.40%
Payout ratio31.18%
Ex-dividend dateJul 29, 2026
Next pay date—
Last split—
Split date—
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 5m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 6m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 6m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 15m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 17m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 27m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 28m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.